Cargando…

What influences aromatase inhibitor continuation intention among breast cancer survivors?

PURPOSE: Aromatase inhibitors (AIs) are widely prescribed for postmenopausal women with breast cancer and are known to cause musculoskeletal pain. This study aimed to identify factors associated with AI continuation intention among breast cancer survivors (BCS). METHODS: A cross-sectional survey was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Young Kyung, Park, Jeongok, Park, Jin-Hee, Kim, Sue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Women Health Nursing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334169/ https://www.ncbi.nlm.nih.gov/pubmed/36311992 http://dx.doi.org/10.4069/kjwhn.2021.01.19

Ejemplares similares

Endothelial Dysfunction in Breast Cancer Survivors on Aromatase Inhibitors: Changes over Time
por: Shaaban, Adnan, et al.
Publicado: (2023)

Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
por: Chim, Kannie, et al.
Publicado: (2013)

Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors
por: Romero, Sally A.D., et al.
Publicado: (2019)

Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
por: Wang, Tao, et al.
Publicado: (2022)

FRI077 Efficacy Of Anti-obesity Medications Among Breast Cancer Survivors Taking Aromatase Inhibitors
por: Fansa, Sima, et al.
Publicado: (2023)

Role of aromatase inhibitors in breast cancer
por: Carpenter, R, et al.
Publicado: (2005)

Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors
por: Park, Jin Young, et al.
Publicado: (2013)

Dietary Supplement Use and Interactions with Tamoxifen and Aromatase Inhibitors in Breast Cancer Survivors Enrolled in Lifestyle Interventions
por: Harrigan, Maura, et al.
Publicado: (2021)

Psychological measures of stress and biomarkers of inflammation, aging, and endothelial dysfunction in breast cancer survivors on aromatase inhibitors
por: Blaes, Anne H., et al.
Publicado: (2023)

The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis
por: Lu, Geling, et al.
Publicado: (2019)

Aromatase Inhibitors to Augment Height: Continued Caution and Study Required
por: Geffner, Mitchell E.
Publicado: (2009)

The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer
por: Fabian, C J
Publicado: (2007)

Quality of life patterns and its association with predictors among non-muscle invasive bladder cancer survivors: A latent profile analysis
por: Park, Jeongok, et al.
Publicado: (2022)

Aromatase inhibitor strategies in metastatic breast cancer
por: McArthur, Heather L, et al.
Publicado: (2010)

Clinical utilities of aromatase inhibitors in breast cancer
por: Chumsri, Saranya
Publicado: (2015)

Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
por: Mao, Jun J, et al.
Publicado: (2011)

Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in Breast Cancer Survivors on Aromatase Inhibitors
por: Wagner, Monica A., et al.
Publicado: (2023)

Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients
por: Seo, Da Hea, et al.
Publicado: (2019)

Characterising an aromatase inhibitor resistant breast cancer cell line
por: Harris, E, et al.
Publicado: (2012)

Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain
por: Nyrop, Kirsten A., et al.
Publicado: (2015)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
por: Jayaraman, Swaathi, et al.
Publicado: (2020)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Molecular response to aromatase inhibitor treatment in primary breast cancer
por: Mackay, Alan, et al.
Publicado: (2007)

Long-term effects of aromatase inhibitors on body mass index among postmenopausal breast cancer survivors in Africa: observational cohort study
por: Milambo, Jean Paul Muambangu, et al.
Publicado: (2023)

Aromatase inhibitors in advanced breast cancer: there are efficacy differences
por: Bhatnagar, A S
Publicado: (2005)

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
por: Miller, WR
Publicado: (2006)

The association between occupational factors, depression, and health-related quality of life in military women in the Republic of Korea: a cross-sectional study
por: Kwon, Eunji, et al.
Publicado: (2021)

Analysis of Perceptions, Preferences, and Participation Intention of Urban Forest Healing Program among Cancer Survivors
por: Park, Eun Young, et al.
Publicado: (2023)

Effect of Combining Impact-Aerobic and Strength Exercise, and Dietary Habits on Body Composition in Breast Cancer Survivors Treated with Aromatase Inhibitors
por: Garcia-Unciti, Marisol, et al.
Publicado: (2023)

Salivary Estrogens Androgens and Aromatase Inhibitors by LC-MS/MS in Breast Cancer Patients Treated With Testosterone Pellets Combined With Aromatase Inhibitors
por: Zava, David T, et al.
Publicado: (2021)

The use of aromatase inhibitors in boys with short stature: what to know before prescribing?
por: Linardi, Alessandra, et al.
Publicado: (2017)

Long-term safety of aromatase inhibitors in the treatment of breast cancer
por: Nabholtz, Jean-Marc A
Publicado: (2008)

Update on the use of aromatase inhibitors in early-stage breast cancer
por: Kesisis, Georgios, et al.
Publicado: (2009)

Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer
por: Haque, Reina, et al.
Publicado: (2012)

Bone Health History in Breast Cancer Patients on Aromatase Inhibitors
por: Kwan, Marilyn L., et al.
Publicado: (2014)

Acquired resistance to everolimus in aromatase inhibitor-resistant breast cancer
por: Kimura, Mariko, et al.
Publicado: (2018)

Network-guided prediction of aromatase inhibitor response in breast cancer
por: Ruffalo, Matthew, et al.
Publicado: (2019)

Effects of Acupuncture on Breast Cancer Patients Taking Aromatase Inhibitors
por: Qi, Qing-ling, et al.
Publicado: (2022)

The genomic landscape associated with resistance to aromatase inhibitors in breast cancer
por: Sadasivam, Kirithika, et al.
Publicado: (2023)

Factors influencing intention to intervene in elder abuse among nursing students
por: Kim, Hee-Jeong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ti9rt6ma454cqsku6h1l217i6